2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Immunoglobulin Light-chain Amyloidosis
3
Multiple Myeloma
2
Amyloidosis
2
Paraproteinemias
1
Monoclonal Gammopathy of Undetermined Significance
1
Amyloid Neuropathies, Familial
1
Interventions
Peripheral Blood Stem Cell Transplantation
4
Cyclophosphamide
4
fludarabine phosphate
3
Epoetin Alfa
3
Darbepoetin alfa
3
Curcumin
3
liposomal amphotericin B
2
Whole-Body Irradiation
2
Tacrolimus
2
Mycophenolic Acid
2
Morphine
2
Microarray Analysis
2
Methylprednisolone
2
Interferon-alpha
2
In Situ Hybridization, Fluorescence
2
Filgrastim
2
Fentanyl
2
Cytogenetic Analysis
2
Cyclosporine
2
Caspofungin
2
Carboplatin
2
Busulfan
2
Bortezomib
2
Biopsy
2
Antilymphocyte Serum
2
tanespimycin
1
siltuximab
1
sargramostim
1
pyroxamide
1
piperine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Monoclonal Gammopathy of Undetermined Significance
×
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
×
Clear all
NCT07624760
2026-06-03
MGUS-PET
University of Zurich
Phase NA
Not yet recruiting
50 enrolled